课题基金 / 基金详情

An androgen receptor coactivator regulated in prostate

An androgen receptor coactivator regulated in prostate
前列腺中调节的雄激素受体共激活剂
批准号:
8761290
负责人:
Susan K. Logan
金额:
$25.59万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-12-19 至 2015-01-31

项目摘要

项目成果

Susan K. Logan的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):本提案的重点是雄激素受体捕获克隆-27(ART-27)和非传统的前折叠蛋白RBP5相互作用蛋白(URI),这两种蛋白质相互作用,并通过雄激素受体(AR)对转录调控产生重大影响。在人类前列腺发育过程中,ART-27在分化的管腔上皮细胞中表达,但在未分化的上皮细胞前体细胞中未检测到,提示ART-27在AR介导的生长抑制和分化中发挥作用。与生长抑制功能一致,ART-27在人前列腺癌中的表达水平降低,并且在雄激素敏感的LNCaP前列腺癌细胞系中的调节表达抑制雄激素介导的细胞增殖。此外,来自前列腺癌的AR(AR P340L)的体细胞改变显示出增强ART-27介导的AR转录激活的能力减弱。此外,最近的一份报告和我们的双杂交结果表明,ART-27与非传统的前折叠蛋白RBP5相互作用元件(URI)与RNA聚合酶的亚基RPB5形成复合体,以控制转录程序。URI与维持基因组完整性有关,最近对分期癌症样本的分析表明,URI是前列腺上皮内瘤变(PIN)中上调的一组基因之一,PIN是一种增殖性病变,被认为是前列腺癌的先兆。基于这些发现,我们假设ART-27是一种细胞类型特异的发育调节蛋白,它将AR与URI转录调节复合体联系起来,并影响在前列腺生长调节中重要的AR靶基因。为了验证这一假设,我们建议:1)确定ART-27依赖的AR靶基因以及ART-27和URI对细胞周期进程的影响;2)确定ART-27和URI是否独立地发挥作用,指导AR介导的基因转录;3)阐明ART-27在体内前列腺上皮细胞生长和分化中的作用。这一建议的压倒一切的假设是,AR辅助因子调节特定的基因转录程序,从而帮助和教唆肿瘤进展。ART-27和URI是转录复合体的新成员,显然在AR信号转导中发挥重要作用,但人们对这些蛋白在前列腺中的功能知之甚少。长期目标是了解AR如何在某些细胞环境中指导细胞的新陈代谢和分化,以及在其他细胞环境中如何指导细胞增殖。
英文摘要
DESCRIPTION (provided by applicant): The focus of this proposal is on Androgen Receptor Trapped clone-27 (ART-27) and Unconventional prefoldin RBP5 Interactor (URI), two proteins that interact with one another and have a major impact on transcriptional regulation through the Androgen Receptor (AR). During prostate development in humans, ART-27 is expressed in differentiated luminal epithelial cells but is not detected in undifferentiated epithelial cell precursors, suggesting a role for ART-27 in AR-mediated growth suppression and differentiation. Consistent with a growth suppressive function, ART-27 expression levels are decreased in human prostate cancer and regulated expression of ART-27 in the androgen sensitive LNCaP prostate cancer cell line inhibits androgen- mediated cellular proliferation. Moreover, a somatic alteration in AR (AR P340L) derived from a prostate cancer shows diminished capacity to enhance ART-27 mediated AR-transcriptional activation. Further, a recent report and our two-hybrid results indicate that ART-27 associates with Unconventional prefoldin RBP5 Interactor (URI) forming complexes with RPB5, a subunit of RNA polymerase, to control transcription programs. URI is implicated in maintenance of genomic integrity and a recent profiling of staged cancer samples indicates that URI is one a group of genes up-regulated in Prostatic Intraepithelial Neoplasia (PIN), a proliferative lesion thought to be a precursor to prostate cancer. Based on these findings, we hypothesize that ART-27 is a cell type specific and developmentally regulated protein that links AR to the URI transcriptional regulatory complex and affects AR target genes important in prostate growth regulation. To test this hypothesis we propose to: 1) Identify ART-27-dependent AR- target genes and the impact of ART-27 and URI on cell cycle progression 2) Determine if ART-27 and URI function independently to direct AR-mediated gene transcription and 3) Elucidate the role of ART-27 in prostate epithelial cell growth and differentiation in vivo. The over-riding hypothesis of this proposal is that AR cofactors modulate specific programs of gene transcription that aid and abet tumor progression. ART-27 and URI are novel members of a transcription complex that clearly play an important role in AR signaling, yet very little is known about the function of these proteins in the prostate. The long-term goal is to understand how AR directs cell metabolism and differentiation in some cellular contexts and proliferation in others.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Suppression of Prostate Cancer
Suppression of Prostate Cancer
An androgen receptor coactivator regulated in prostate
Transcription repression in prostate cancer
海外基金